T1	Participants 130 195	acute exacerbated chronic obstructive pulmonary disease patients]
T2	Participants 372 443	acute exacerbated chronic obstructive pulmonary disease (COPD) patients
T3	Participants 533 592	treatment group (39 cases) and the control group (40 cases)
T4	Participants 2003 2034	acute exacerbated COPD patients
